Tissue‐specific insulin signaling in the regulation of metabolism and aging
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
In mammals, insulin signaling regulates glucose homeostasis and plays an essential role in metabolism, organ growth, development, fertility, and lifespan. The defects in this signaling pathway contribute to various metabolic diseases such as type 2 diabetes, polycystic ovarian disease, hypertension, hyperlipidemia, and atherosclerosis. However, reducing the insulin signaling pathway has been found to increase longevity and delay the aging‐associated diseases in various animals, ranging from nematodes to mice. These seemly paradoxical findings raise an interesting question as to how modulation of the insulin signaling pathway could be an effective approach to improve metabolism and aging. In this review, we summarize current understanding on tissue‐specific functions of insulin signaling in the regulation of metabolism and lifespan. We also discuss the potential benefits and limitations in modulating tissue‐specific insulin signaling pathway to improve metabolism and healthspan. © 2014 IUBMB Life, 66(7):485–495, 2014
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795 · cited 1×
“Insulin resistance in adipose tissue, which is a characteristic of the obese state (73), has been recognized as one of the leading causes of type 2 diabetes (74, 75).”
BackgroundRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“Suppression of mTOR signaling extends lifespan in yeast (147, 148), worms (149), Drosophila (150), and mice (151).”
BackgroundMuscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909 · cited 1×
“Recent studies have identified skeletal muscles as a secretory organ that secretes several hundred peptides (myokines) in response to environmental and/or metabolic changes (37).”
BackgroundPathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · cited 1×
“elegans (114), flies (115), mice (116), and humans (117, 118).”
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · cited 1×
“The action of insulin in the regulation of lipid metabolism is mediated by two main transcriptional factors: SREBP1c, which determines the transcription of many adipocyte-specific genes (56, 57), and FOXO1 (58).”
BackgroundGlucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295 · cited 1×
“Insulin stimulates the translocation of the glucose transporter GLUT4 from intracellular pools to the surface of cell membrane to increase glucose uptake in adipose and muscle (54).”
BackgroundDeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 1×
“Muscle is one of the major sites of insulin resistance in type 2 diabetic patients (29) and in fact, muscle insulin resistance has been considered to be one of the earliest signs in the pathogenesis of metabolic syndrome (30).”
BackgroundChronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D. (1979) · Nature · doi:10.1038/282503a0 · Cited by 1,114
Development of obesity in transgenic mice after genetic ablation of brown adipose tissue
Lowell, B. B., S-Susulic, V., Hamann, A., Lawitts, J. A., Himms-Hagen, J., Boyer, B. B., Kozak, L. P., & Flier, J. S. (1993) · Nature · doi:10.1038/366740a0 · Cited by 1,075 · cited 1×
“which is important for thermal adaptation as well as determining peripheral insulin sensitivity (78), led to age-dependent brown fat atrophy, accompanied with deteriorated b cell function, decreased b cell mass, and hyperglycemia (79).”
BackgroundInfluence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Copps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017 · cited 1×
“Insulin signaling is negatively regulated by a number of mechanisms, such as the binding of the adaptor protein Grb10 to the kinase domain of IR ((8), (9)), serine phosphorylation of IRS1 ((10), (11)), and dephosphorylation of IR and IRS1/2 by protein tyrosine phosphatase-1B (PTP-1B) (12).”
BackgroundRegulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Magnuson, B., Ekim, B., & Fingar, D. C. (2012) · Biochemical Journal · doi:10.1042/bj20110892 · Cited by 1,015
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
Adipose tissue as a buffer for daily lipid flux
Frayn, K. (2002) · Diabetologia · doi:10.1007/s00125-002-0873-y · Cited by 752
Functionally significant insulin-like growth factor I receptor mutations in centenarians
Suh, Y., Atzmon, G., Cho, M.-O., Hwang, D., Liu, B., Leahy, D. J., Barzilai, N., & Cohen, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705467105 · Cited by 703 · cited 1×
“elegans (114), flies (115), mice (116), and humans (117, 118).”
Calorie restriction and aging: review of the literature and implications for studies in humans
Heilbronn, L. K., & Ravussin, E. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.361 · Cited by 701 · cited 1×
“Consistent with this, caloric restriction, a well-established strategy to extend lifespan in rodents, reduces fat mass, particularly visceral fat, in mice (77, 135).”
BackgroundInsulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695
Insulin effects in muscle and adipose tissue
Dimitriadis, G., Mitrou, P., Lambadiari, V., Maratou, E., & Raptis, S. A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70014-6 · Cited by 649 · cited 2×
“Disruption of Insulin Signaling in Adipose Tissues Improves Healthy Aging and Extends Lifespan Insulin lowers plasma FA levels by inhibiting lipolysis and stimulating FA and triacylglycerol synthesis and by promoting triglyceride uptake in adipose tissues (51).”
BackgroundThe diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk
Pedersen, B. K. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179515 · Cited by 631 · cited 1×
“Among them, the brain-derived neurotrophic factor (38) and irisin (39) have been shown to regulate glucose homeostasis and obesity by crosstalking with other organs (e.”
BackgroundBrain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis
Taguchi, A., Wartschow, L. M., & White, M. F. (2007) · Science · doi:10.1126/science.1142179 · Cited by 523 · cited 2×
“Deletion of IRS2 specifically in the brain increases lifespan in the presence of peripheral insulin resistance (110).”
BackgroundAdipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
Polak, P., Cybulski, N., Feige, J. N., Auwerx, J., Rüegg, M. A., & Hall, M. N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.003 · Cited by 480 · cited 1×
“Interestingly, adiposespecific disrupting mTORC1 signaling by knocking out Raptor prevented diet-induced obesity in mice (156).”
BackgroundBarbieri, M., Bonafè, M., Franceschi, C., & Paolisso, G. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00296.2003 · Cited by 456
Insulin signaling in the central nervous system: Learning to survive
van der Heide, L. P., Ramakers, G. M. J., & Smidt, M. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.06.003 · Cited by 444 · cited 4×
“AD is associated with a decrease in insulin level in the CSF and CSF/plasma insulin ratio (104) and insulin signaling impairment is more severe in individuals with both T2DM and AD ((130), (131)), suggesting that T2DM may be a risk factor for AD.”
BackgroundInfluentialZierath, J. R., He, L., Gumà, A., Wahlström, E. O., Klip, A., & Wallberg-Henriksson, H. (1996) · Diabetologia · doi:10.1007/bf02658504 · Cited by 402 · cited 1×
“The defects in glucose transport in skeletal muscle also correlate with impaired whole-body glucose uptake in type 2 diabetic patients (32).”
BackgroundKrook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.284 · Cited by 375 · cited 1×
“Impaired tyrosine phosphorylation of IRS1 and activation of PI3K have been found in skeletal muscle of type 2 diabetic patients (31).”
BackgroundKim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 1×
“A possible explanation for these findings is that glucose is shunted from insulin-resistant muscle to the relatively more insulin-sensitive adipose tissue where it is converted into triglyceride for storage, and thus compensating for reduced muscle insulin sensitivity at the whole-body level in the mice (33).”
BackgroundFoxo1 integrates insulin signaling with mitochondrial function in the liver
Cheng, Z., Guo, S., Copps, K., Dong, X., Kollipara, R., Rodgers, J. T., Depinho, R. A., Puigserver, P., & White, M. F. (2009) · Nature Medicine · doi:10.1038/nm.2049 · Cited by 321 · cited 1×
“However, liver-specific knockout of both IRS1 and IRS2 leads to severe glucose intolerance and impaired lipid metabolism (24).”
BackgroundPOWELL, D. J., TURBAN, S., GRAY, A., HAJDUCH, E., & HUNDAL, H. S. (2004) · Biochemical Journal · doi:10.1042/bj20040139 · Cited by 267 · cited 2×
“In contrast, palmitate, by elevating intracellular synthesis of ceramide and activation of protein kinase PKCf (35), suppresses insulininduced plasma membrane recruitment and phosphorylation of Akt, which is associated with a loss in insulin-stimulated”
BackgroundKubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.007 · Cited by 244 · cited 1×
“Conversely, liver-specific IRS2 knockout (LIRS2-KO) mice display insulin resistance during fasting but not after refeeding, displaying dynamic functional relay (22).”
BackgroundInsulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus
Kubota, N., Terauchi, Y., Tobe, K., Yano, W., Suzuki, R., Ueki, K., Takamoto, I., Satoh, H., Maki, T., Kubota, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21484 · Cited by 239 · cited 13×
“FIG 2 IUBMB LIFE 490 Insulin Signaling In Metabolism and Aging knockout of IRS2, but not neuronal IR or IGF-1R, prevents premature death and delays amyloid accumulation in a mouse model of AD (134).”
MethodInfluentialFreude, S., Hettich, M. M., Schumann, C., Stöhr, O., Koch, L., Köhler, C., Udelhoven, M., Leeser, U., Müller, M., Kubota, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132043 · Cited by 218 · cited 1×
“knockout of IRS2, but not neuronal IR or IGF-1R, prevents premature death and delays amyloid accumulation in a mouse model of AD (134).”
BackgroundSkeletal muscle insulin resistance: roles of fatty acid metabolism and exercise
Turcotte, L. P., & Fisher, J. S. (2008) · Physical Therapy · doi:10.2522/ptj.20080018 · Cited by 209
Reduced β-cell mass and altered glucose sensing impair insulin-secretory function in βIRKO mice
Otani, K., Kulkarni, R. N., Baldwin, A. C., Krutzfeldt, J., Ueki, K., Stoffel, M., Kahn, C. R., & Polonsky, K. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00533.2001 · Cited by 185
Hot topics in aging research: protein translation and TOR signaling, 2010
Kaeberlein, M., & Kennedy, B. K. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00665.x · Cited by 66
Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance
Blaak, E. E. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.04.001 · Cited by 57 · cited 1×
“Insulin has also been shown to stimulate glucose and free FA uptake in skeletal muscle by increasing glucose flux and activating key enzymes involved in muscle glucose or fat oxidation (27).”
Background
Research works printed but not linked: 115
- 10.4158/EP.14.3.373 · DOI
- 10.1172/JCI10830 · DOI · Paper page
- 10.1007/s00018-004-4297-y · DOI · Paper page
- 10.2337/diabetes.54.5.1264 · DOI · Paper page
- 10.1016/j.celrep.2014.04.006 · DOI · Paper page
- 10.2741/1226 · DOI
- 10.1042/BJ20050216 · DOI · Paper page
- 10.1530/JOE-13-0584 · DOI · Paper page
- 10.1111/j.1742-4658.2012.08563.x · DOI · Paper page
- Lewis G. F., 1997, Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans, Am. J. Physiol., 272, E371
- 10.1172/JCI108649 · DOI · Paper page
- Hendrick G. K., 1990, Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast, Am. J. Physiol., 258, E841
- 10.1152/ajpendo.2000.279.3.E630 · DOI · Paper page
- 10.1172/JCI118846 · DOI · Paper page
- Sindelar D. K., 1997, The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog, Diabetes, 46, 187, 10.2337/diab.46.2.187 · DOI · Paper page
- 10.1016/j.cmet.2006.02.009 · DOI · Paper page
- 10.1016/S1097-2765(05)00015-8 · DOI · Paper page
- 10.1128/MCB.00138-09 · DOI · Paper page
- 10.2337/diab.30.12.1000 · DOI · Paper page
- 10.1152/ajpendo.1996.270.1.E197 · DOI · Paper page
- 10.1016/S1097-2765(00)80155-0 · DOI · Paper page
- Rabol R. Petersen K. F. Dufour S. Flannery C. Shulman G. I.(2011)Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals.Proc. Natl. Acad. Sci. USA.108 13705–13709. · DOI · Paper page
- 10.1128/MCB.00983-10 · DOI · Paper page
- 10.1210/jc.2013-2373 · DOI · Paper page
- 10.2337/db11-0915 · DOI · Paper page
- 10.1080/07853890510037383 · DOI · Paper page
- 10.1172/JCI11245 · DOI · Paper page
- Penkov D. N., 2013, Insulin resistance and adipogenesis: role of transcription and secreted factors, Biochemistry, 78, 8
- 10.2337/diacare.15.3.318 · DOI · Paper page
- 10.1055/s-2001-18582 · DOI
- 10.1007/s00125-013-2869-1 · DOI · Paper page
- 10.1016/S1534-5807(02)00199-5 · DOI · Paper page
- 10.1210/jc.2005-0960 · DOI · Paper page
- 10.1055/s-2001-18575 · DOI
- 10.1038/371762a0 · DOI · Paper page
- 10.1172/JCI1411 · DOI · Paper page
- 10.1038/nm.2686 · DOI · Paper page
- 10.1128/MCB.19.5.3760 · DOI · Paper page
- 10.1073/pnas.96.24.13656 · DOI · Paper page
- 10.1038/nature10986 · DOI · Paper page
- 10.1074/jbc.M112.365544 · DOI · Paper page
- 10.1016/j.bbrc.2011.07.038 · DOI
- 10.1042/BJ20090842 · DOI
- 10.1128/MCB.00797-10 · DOI · Paper page
- 10.1074/jbc.M804146200 · DOI · Paper page
- 10.1038/nm.1904 · DOI · Paper page
- 10.1074/jbc.C800241200 · DOI · Paper page
- 10.1016/j.cmet.2011.02.005 · DOI · Paper page
- 10.1074/jbc.M600320200 · DOI · Paper page
- 10.1074/jbc.M707404200 · DOI · Paper page
- 10.1152/ajpendo.00104.2007 · DOI
- 10.1038/nm.2014 · DOI · Paper page
- 10.1038/sj.ijo.0802028 · DOI · Paper page
- 10.1126/science.1078223 · DOI · Paper page
- 10.1172/JCI13103 · DOI · Paper page
- 10.1038/35055575 · DOI · Paper page
- 10.4161/isl.1.2.9263 · DOI
- 10.1113/jphysiol.1941.sp003930 · doi:10.1113/jphysiol.1941.sp003930
- 10.1016/S0014-5793(02)03627-X · DOI
- 10.1146/annurev.nutr.28.061807.155530 · DOI · Paper page
- 10.2337/diabetes.47.8.1243 · DOI
- 10.1016/S0092-8674(00)80546-2 · DOI · Paper page
- 10.1172/JCI8339 · DOI · Paper page
- 10.1038/36116 · DOI · Paper page
- 10.1007/s00125-007-0637-9 · DOI
- 10.1038/nm1001-1133 · DOI · Paper page
- 10.2337/db13-0246 · DOI
- 10.1126/stke.2682005pe4 · DOI · Paper page
- 10.1210/edrv-2-4-471 · DOI · Paper page
- Porte D., 1969, Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus, Arch. Intern. Med., 123, 252, 10.1001/archinte.1969.00300130034006 · doi:10.1001/archinte.1969.00300130034006
- 10.1038/ng872 · DOI · Paper page
- 10.1038/ng1787 · DOI · Paper page
- 10.2337/db10-0624 · DOI · Paper page
- 10.1002/dvg.20672 · DOI · Paper page
- 10.1074/jbc.M512373200 · DOI · Paper page
- 10.1023/A:1022598900246 · DOI · Paper page
- 10.1016/j.tem.2005.01.008 · DOI · Paper page
- 10.1155/2012/384017 · DOI · Paper page
- 10.14348/molcells.2014.2251 · DOI
- 10.1126/science.1057987 · DOI · Paper page
- 10.1007/s11357-012-9491-x · DOI
- 10.2337/db11-0390 · DOI · Paper page
- 10.1038/366461a0 · DOI · Paper page
- 10.1038/nature02549 · DOI · Paper page
- 10.1126/science.1071851 · DOI · Paper page
- 10.1111/j.1474-9726.2007.00348.x · DOI · Paper page
- 10.1093/genetics/143.3.1207 · DOI · Paper page
- 10.1038/20208 · DOI · Paper page
- 10.1093/genetics/163.1.35 · DOI · Paper page
- 10.1126/science.1057991 · DOI · Paper page
- 10.1093/toxsci/52.suppl_1.35 · DOI · Paper page
- Dunn S. E., 1997, Dietary restriction reduces insulin‐like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53‐deficient mice, Cancer Res., 57, 4667
- 10.2337/diabetes.53.7.1824 · DOI · Paper page
- 10.1016/j.ejphar.2004.02.045 · DOI · Paper page
- 10.1073/pnas.0308724101 · DOI · Paper page
- 10.1002/path.2912 · DOI · Paper page
- 10.1172/JCI57256 · DOI · Paper page
- 10.2337/db11-1186 · DOI · Paper page
- 10.2337/diabetes.52.8.2129 · DOI · Paper page
- 10.1073/pnas.81.6.1835 · DOI · Paper page
- 10.1126/science.290.5489.147 · DOI · Paper page
- 10.1126/science.277.5328.942 · DOI · Paper page
- 10.18632/aging.100040 · DOI · Paper page
- 10.1152/physiol.00024.2006 · DOI · Paper page
- 10.1038/nature06639 · DOI · Paper page
- 10.1146/annurev.biochem.68.1.913 · DOI · Paper page
- 10.1111/j.1474-9726.2007.00341.x · DOI · Paper page
- 10.1016/j.cell.2012.03.017 · DOI · Paper page
- 10.1016/j.cmet.2007.02.009 · DOI · Paper page
- 10.1126/science.1115535 · DOI · Paper page
- 10.1016/j.cub.2004.03.059 · DOI · Paper page
- 10.1016/j.ajpath.2012.06.024 · DOI
- 10.1016/j.molcel.2006.03.029 · DOI · Paper page
- 10.1155/2013/849186 · DOI · Paper page
- 10.1016/j.cmet.2014.03.018 · DOI · Paper page
Cited by
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“The pancreas is mainly composed of four types of cells, of which pancreatic β cells are vitally important in maintaining glucose homeostasis by producing and secreting insulin in response to the blood glucose concentration [58].”
BackgroundInfluentialContribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus
Burhans, M. S., Hagman, D. K., Kuzma, J. N., Schmidt, K. A., & Kratz, M. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170040 · Cited by 373
Skeletal muscle transcriptome in healthy aging
Tumasian, R. A., Harish, A., Kundu, G., Yang, J.-H., Ubaida-Mohien, C., Gonzalez-Freire, M., Kaileh, M., Zukley, L. M., Chia, C. W., Lyashkov, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22168-2 · Cited by 126
Tegegne, B. A., Adugna, A., Yenet, A., Yihunie Belay, W., Yibeltal, Y., Dagne, A., Hibstu Teffera, Z., Amare, G. A., Abebaw, D., Tewabe, H., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1440456 · Cited by 61
Omura, T., & Araki, A. (2022) · Geriatrics & Gerontology International · doi:10.1111/ggi.14339 · Cited by 47
Metadata
- Authors
- Zhang, J., & Liu, F.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2014-07
- Volume
- 66
- Issue
- 7
- Pages
- 485-495
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W1605041796
- Cited by
- 103
- References
- 41
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- National Natural Science Foundation of China (81130015, 81000316, 81370017)
- National Institutes of Health (RO1 DK100697)
- Natural Science Foundation of Hunan Province, China (14JJ3034)
- the National Basic Research Program of China (2014CB910500)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.